MFN Drug Pricing Targets: Lowering U.S. Drug Co...

By Rene Pretorius

May 21, 2025

Summary The U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) have set Most-Favored-Nation (MFN)
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
South Africa NHI Bill Court Ruling Calls for Scrutiny
Wegovy CVS Deal: Hybrid Market Access Strategy Insights
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
Toripalimab Evidence Journey in Cancer Care
HPV Testing in Head and Neck Squamous Cell Carcinoma
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?
Advancing Heart Transplantation: The Role of the Lumped Parameter Model
Molecular Insights into Angiogenesis in Colorectal Cancer